Form 4 for TECH Bio-Techne
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001062993-25-014698 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-15 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | F - Tax | $53.60 | -880 | 4,735 | -16% | -$47.2K |
| D | 2025-08-19 | 2025-08-15 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | M - OptEx | $0.00 | +2,637 | 5,615 | +89% | $0 |
| DM | 2025-08-19 | 2025-08-15 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | A - Grant | $0.00 | +53.5K | 24.6K | New | $0 |
| D | 2025-08-19 | 2025-08-15 | TECH | McManus Matthew | Pres - Diag, Spatial Bio | M - OptEx | $0.00 | -2,637 | 5,275 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | F | D | 880 | $53.60 | 4,735 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-15 | M | A | 2,637 | $0.00 | 5,615 | D | — | — | |
| 3 | Derivative | Performance Restricted Stock Units | 2025-08-15 | A | A | 19,243 | $0.00 | 19,243 | D | — · — to — | 19,243 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F8) Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 4 | Derivative | Restricted Stock Units | 2025-08-15 | A | A | 9,622 | $0.00 | 9,622 | D | — · — to — | 9,622 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F9) 3,207 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 3,208 restricted stock units vest on 8/15/2028. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-08-15 | A | A | 24,614 | $0.00 | 24,614 | D | $53.60 · — to 2035-08-15 | 24,614 Common Stock | (F10) Options to purchase 8,205 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,204 shares vest on 8/15/2028. |
| 6 | Derivative | Restricted Stock Units | 2025-08-15 | M | D | 2,637 | $0.00 | 5,275 | D | — · — to — | 2,637 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F6) 2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027. |